Literature DB >> 16766197

Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice.

Arianna Bellucci1, Ilaria Luccarini, Carla Scali, Costanza Prosperi, Maria Grazia Giovannini, Giancarlo Pepeu, Fiorella Casamenti.   

Abstract

In 7-month-old TgCRND8 mice, the extracellular cortical acetylcholine levels in vivo, the number and morphology of cholinergic neurons in the nucleus basalis magnocellularis and the ability to acquire an inhibitory avoidance response in the step-down test were studied. The TgCRND8 mouse brain is characterized by many beta-amyloid plaques, reduced neuronal and axonal staining, white matter demyelination, glia reaction and inducible nitric oxide synthase immunoreactivity. Choline acetyltransferase immunoreactivity in the nucleus basalis magnocellularis was significantly decreased. Basal and potassium-stimulated extracellular acetylcholine levels, investigated by microdialysis, and m2 muscarinic receptor immunoreactivity were reduced in the cortex of TgCRND8 mice, and scopolamine administration increased cortical extracellular acetylcholine levels in control but not in TgCRND8 mice. A cognitive impairment was demonstrated in the step-down test. These findings demonstrate that neuronal damage and cholinergic dysfunction in vivo underlie the impairment in learning and memory functions in this mouse model of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766197     DOI: 10.1016/j.nbd.2006.03.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  40 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Object recognition memory and BDNF expression are reduced in young TgCRND8 mice.

Authors:  Beverly M Francis; John Kim; Meredith E Barakat; Stephan Fraenkl; Yeni H Yücel; Shiyong Peng; Bernadeta Michalski; Margaret Fahnestock; Joanne McLaurin; Howard T J Mount
Journal:  Neurobiol Aging       Date:  2010-05-05       Impact factor: 4.673

Review 3.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Nonlinear dynamical analysis of carbachol induced hippocampal oscillations in mice.

Authors:  Metin Akay; Kui Wang; Yasemin M Akay; Andrei Dragomir; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

5.  Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.

Authors:  Shiyong Peng; Diego J Garzon; Monica Marchese; William Klein; Stephen D Ginsberg; Beverly M Francis; Howard T J Mount; Elliott J Mufson; Ahmad Salehi; Margaret Fahnestock
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

6.  Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-β protein precursor transgenic mice.

Authors:  Jennifer H K Choi; Gurjinder Kaur; Matthew J Mazzella; Jose Morales-Corraliza; Efrat Levy; Paul M Mathews
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  DEEP BRAIN STIMULATION IN MIDLINE THALAMIC REGION FACILITATES SYNAPTIC TRANSMISSION AND SHORTTERM MEMORY IN A MOUSE MODEL OF ALZHEIMER'S DISEASE.

Authors:  Isabel Arrieta-Cruz; Constantine Pavlides; Giulio Maria Pasinetti
Journal:  Transl Neurosci       Date:  2010-09       Impact factor: 1.757

8.  Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.

Authors:  Magali Dumont; Elizabeth Wille; Noel Y Calingasan; Davide Tampellini; Charlotte Williams; Gunnar K Gouras; Karen Liby; Michael Sporn; Carl Nathan; M Flint Beal; Michael T Lin
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

9.  Functional restoration using basic fibroblast growth factor (bFGF) infusion in Kainic acid induced cognitive dysfunction in rat: neurobehavioural and neurochemical studies.

Authors:  Nishi Srivastava; Kavita Seth; Nalini Srivastava; Vinay K Khanna; Ashok Kumar Agrawal
Journal:  Neurochem Res       Date:  2007-10-23       Impact factor: 3.996

10.  Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.

Authors:  Latha Devi; Masuo Ohno
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.